Letter Sequence Approval |
|---|
|
Results
Other: ML20338A160, ML20338A165, ML21026A001, ML21055A810, ML21055A820, ML21110A147, ML21110A148, ML21159A143, ML21187A126, ML21204A101, ML21309A105, ML22109A121, ML22200A061, ML22259A001, ML24040A176, ML24040A179, ML24044A062, ML24044A063
|
MONTHYEARML19221B7422019-08-30030 August 2019 Proprietary Determination Letter for ANP-10337, Revision 0, Supplement 1P, Revision 0, Deformable Spacer Grid Element RAI Response Project stage: RAI ML19347C1932019-12-10010 December 2019 Email Transmittal of Request for Additional Information Questions Regarding Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: RAI ML20083K3862020-03-26026 March 2020 Round 1 Request for Additional Information Questions for the Review of Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology (Non-Proprietary) Project stage: RAI ML20338A1652020-12-10010 December 2020 Regulatory Audit Plan for Framatome Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project No. 728 Project stage: Other ML20338A1602020-12-10010 December 2020 December 7 - 11, 2020, Regulatory Audit Plan for Framatome Inc. Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML21026A0012021-02-0909 February 2021 Audit Report Letter for Framatome Topical Report ANP-10229P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML21055A8102021-03-0101 March 2021 March 3, 4, 24, 25, and 26, 2021 Regulatory Audit Plan for Framatome Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project No. 728 EPID L-2018-TOP-0034 Project stage: Other ML21055A8202021-03-0101 March 2021 March 3, 4, 24, 25, and 26, 2021, Regulatory Audit Plan Letter for Framatome Inc. Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML21110A1472021-05-0404 May 2021 April 22, 2021, Audit Plan for Framatome Inc. Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology (EPID L-2018-TOP-0034) (Letter) Project stage: Other ML21110A1482021-05-0404 May 2021 April 22, 2021, Audit Plan for Framatome Inc. Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML21159A1432021-06-11011 June 2021 June 15, 2021, Regulatory Audit Plan for Framatome Inc. Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML21187A1262021-07-0909 July 2021 July 9, 2021 Audit Plan for Framatome Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML21204A1012021-07-27027 July 2021 August 11-12, 2021, Regulatory Audit Plan for Framatome Inc. Topical Report, ANP-10339P, Revision 0, Arita - ARTEMIS-RELAP Integrated Transient Analysis Methodology Project stage: Other ML21309A1052021-11-0808 November 2021 November 8, 2021 Audit Plan for Framatome Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML22109A1212022-04-22022 April 2022 April 20 - 21, and 28, 2022, Regulatory Audit Plan for Framatome Inc. Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML22097A2642022-04-26026 April 2022 U.S. Nuclear Regulatory Commissions Revised Schedule for Review of Framatome Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Approval ML22200A0612022-07-25025 July 2022 Report for 2021 - 2022, Regulatory Audits Regarding Framatome Inc. Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML22259A0012022-10-0505 October 2022 Schedule Change Letter for Framatome Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML22357A0822023-01-0909 January 2023 The U.S. Nuclear Regulatory Commissions Revised Schedule for the Review of Framatome’S Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Approval ML23006A2522023-01-17017 January 2023 Summary of Closed Hybrid Meeting with Framatome Inc. and the U. S. Nuclear Regulatory Commission for Topical Report, Anp 10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Meeting PMNS20230079, Closed Meeting with the Nuclear Regulatory Commission and Framatome Regarding Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology2023-01-30030 January 2023 Closed Meeting with the Nuclear Regulatory Commission and Framatome Regarding Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Request ML23072A3862023-04-0606 April 2023 Summary of March 2, 3023, Closed Meeting with Framatome Inc. and the U.S. Nuclear Regulatory Commission for Topical Report, ANP-10339P, Revision 0, ARITA-ARTEMIS/RELAP Integrated Transient Analysis Methodology Project stage: Meeting PMNS20230725, Closed Meeting with the Nuclear Regulatory Commission and Framatome Regarding Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology2023-06-0909 June 2023 Closed Meeting with the Nuclear Regulatory Commission and Framatome Regarding Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Request ML23177A2582023-07-10010 July 2023 Summary of June 20, 2023, Closed Meeting with Framatome Inc. and the U.S. Nuclear Regulatory Commission for Topical Report, Anp 10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Meeting PMNS20231147, Closed Meeting with the Nuclear Regulatory Commission and Framatome Regarding Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology2023-10-0606 October 2023 Closed Meeting with the Nuclear Regulatory Commission and Framatome Regarding Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Request ML23233A1392023-10-16016 October 2023 Final Safety Evaluation for Framatome Topical Report Anp 10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology (EPID L 2018-TOP-0034) Letter Project stage: Approval ML23299A2402023-10-16016 October 2023 Final Safety Evaluation for Framatome Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology (Appendix IV) - Non-Proprietary Project stage: Approval ML23299A2322023-10-16016 October 2023 Final Safety Evaluation for Framatome Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology - Non-Proprietary Project stage: Approval ML23305A0642023-11-0505 November 2023 Summary of October 19, 2023, Closed Meeting with Framatome Inc. and the U.S. Nuclear Regulatory Commission for Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Meeting ML24044A0632024-02-13013 February 2024 Transmittal Withholding Determination for Publication of Framatome Topical Report, ANP-10339P, Rev. 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML24044A0622024-02-13013 February 2024 Withholding Determination for Publication of Framatome Topical Report, ANP-10339P, Rev. 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML24040A1792024-04-16016 April 2024 Verification for Publication of Framatome Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Topical Report Project stage: Other ML24040A1762024-04-22022 April 2024 Verification for Publication of Framatome Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Transmittal (EPID L-2018-TOP-0034) - Email Project stage: Other 2022-04-26
[Table View] |
Text
OFFICIAL USE ONLY - PROPRIETARY INFORMATION OFFICIAL USE ONLY - PROPRIETARY INFORMATION October 16, 2023 Ms. Gayle Elliott, Director Licensing and Regulatory Affairs Framatome, Inc.
3315 Old Forest Road Lynchburg, VA 24501
SUBJECT:
FINAL SAFETY EVALUATION FOR FRAMATOME TOPICAL REPORT ANP-10339P, REVISION 0, ARITA - ARTEMIS/RELAP INTEGRATED TRANSIENT ANALYSIS METHODOLOGY (EPID L 2018-TOP-0034)
Dear Ms. Elliott:
By letter dated August 28, 2018 (Agencywide Documents Access and Management System Package Accession No. ML18242A480), as supplemented by letters dated March 14, 2019 (ADAMS Package Accession No. ML19078A260), March 31, 2020 (ADAMS Package Accession No. ML20097E582), July 31, 2020 (ADAMS Package Accession No. ML20237F488),
November 20, 2020 (ADAMS Package Accession No. ML20335A217), June 2, 2021 (ADAMS Package Accession No. ML21162A080), and June 30, 2022 (ADAMS Package Accession No. ML22193A169), Framatome, Inc. (Framatome) submitted Topical Report (TR)
ANP-10339P, Revision 0, ARITA - ARTEMIS/RELAP Integrated Transient Analysis Methodology, for U.S. Nuclear Regulatory Commission (NRC) staff review. By letter dated December 18, 2018 (ADAMS Accession No. ML18345A159), the NRC staff accepted the TR for review.
By e-mail dated April 17, 2023 (ADAMS Package Accession No. ML23068A466), an NRC draft safety evaluation (SE) regarding approval of ANP-10339P, Revision 0, was provided to Framatome for proprietary review. By letter dated June 30, 2023 (ADAMS Package Accession No. ML23181A144), Framatome provided comments on the draft SE. The NRC staffs disposition of the Framatome comments on the draft SE is provided in the attachment of the final SE which is enclosed with this letter.
The NRC staff has found that ANP-10339P, Revision 0, is acceptable for referencing in licensing applications for nuclear power plants to the extent specified and under the limitations delineated in the TR and in the enclosed final SE. The final SE defines the basis for NRC acceptance of the TR.
NOTICE: Enclosure 1 and its Attachment to this letter contain Proprietary Information. When this letter is separated from Enclosure 1 and its Attachment, this letter is decontrolled.
OFFICIAL USE ONLY - PROPRIETARY INFORMATION OFFICIAL USE ONLY - PROPRIETARY INFORMATION The NRC acceptance applies only to material provided in the subject TR. The NRC does not intend to repeat its review of the acceptable material described in the TR. When the TR appears as a reference in licensing applications, the NRC review will ensure that the material presented applies to the specific plant involved. License amendment requests that deviate from this TR will be subject to a plant specific review in accordance with applicable NRC review standards.
In accordance with the guidance provided on the NRC website, we request that Framatome publish approved proprietary and non-proprietary versions of TR ANP-10339P, Revision 0, within three months of receipt of this letter. The approved versions shall incorporate this letter and the enclosed final SE after the title page. For non-proprietary versions, Framatome shall strike the proprietary information markings in this letter and make the appropriate redactions and adjustments to document security classifications to the enclosed SE. Also, they must contain historical review information, including the NRC request for additional information (RAI) questions and Framatomes responses. The approved versions shall include a "-A" (designating approved) following the TR identification symbol.
As an alternative to including the RAI questions and RAI responses behind the title page, if changes to the TR were provided to the NRC staff to support the resolution of RAI responses, and the NRC staff reviewed and approved those changes as described in the RAI responses, there are two ways that the accepted version can capture the RAI questions:
- 1. The RAI questions and RAI responses can be included as an Appendix to the accepted version.
- 2. The RAI questions and RAI responses can be captured in the form of a table (inserted after the final SE) which summarizes the changes as shown in the approved version of the TR.
The table should reference the specific RAI questions and RAI responses which resulted in any changes as shown in the accepted version of the TR.
If future changes to the NRCs regulatory requirements affect the acceptability of this TR, Framatome will be expected to revise the TR appropriately or justify its continued applicability for subsequent referencing.
Sincerely,
/RA/
Gerond A. George, Chief Licensing Projects Branch Division of Operating Reactor Licensing Office of Nuclear Reactor Regulation Docket No. 99902041 Project No. 728
Enclosures:
- 1. Final SE (Proprietary)
- 2. Final SE (Non-Proprietary)
ML23233A151 (Package)
ML23233A139 (Letter)
ML23233A144 (Final SE - proprietary)
ML23299A232 (Final SE - non-proprietary)
ML23233A145 (Appendix IV - proprietary)
ML23299A240 (Appendix IV - non-proprietary)
- concurrence via e-mail OFFICE NRR/DORL/LLPB/PM*
NRR/DORL/LLPB/LA*
NRR/DSS/SFNB/BC*
NAME Notto DHarrison SKrepel DATE 08/21/2023 08/31/2023 08/31/2023 OFFICE OGC - NLO NRR/DORL/LLPB/BC*
NRR/DORL/LLPB/PM*
NAME MASpencer GGeorge NOtto DATE 10/13/2023 10/16/2023 10/16/2023